Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.
Massa D, Foukakis T, Giacchetti S, Desmedt C, Frenel JS, Gasparini E, Kok M, Vigneri P, Jacot W, Vernieri C, Lambertini M, Patanè F, Piacentini F, Bria E, Zambelli A, Trapani D, Botticelli A, Garrone O, Lando S, Matikas A, Someil L, Floris G, Campone M, Ragazzi M, Lips E, Martorana F, Bonomi G, Papakonstantinou A, Nicolè L, Zerdes I, Neven P, Rotolo M, Horlings H, Nucera S, Gudin-De-Vallerin A, Vingiani A, Dei Tos AP, Guarneri V, Dieci MV; GAMBIT Consortium.
Massa D, et al. Among authors: papakonstantinou a.
Nat Commun. 2026 Jun 24. doi: 10.1038/s41467-026-74056-2. Online ahead of print.
Nat Commun. 2026.
PMID: 42343076
Free article.